Meda in the US

📍 United States👥 248 employees💰 Last funded May 2012
Pharmaceutical Manufacturing🌐 medapharma.us
Website LinkedIn
Meda is a leading international specialty pharma company with a broad product portfolio reaching more than 80% of the global pharmaceutical market. Sales at the end of 2014 amounted to more than SEK 15 billion (pro forma SEK 18.7 billion). Meda is thereby the 48th largest pharmaceutical company in the world. At the end of 2014 Meda had 5,202 (3,326) employees, 2,996 (2,009) of which worked in sales and marketing. The company’s main focus is sales and marketing and Meda has its own sales organizations in more than 60 countries. Sales and marketing activities are carried out via distributors in countries where Meda has no representation and globally Meda’s products are sold in more than 150 countries. Meda in the US is headquartered in Somerset, New Jersey.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Meda in the US?
Meda in the US has 2 investors on record on gritt.io.
When did Meda in the US last raise funding?
The most recent investment in Meda in the US recorded on gritt.io was in May 2012.
What industry is Meda in the US in?
Meda in the US operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Meda in the US based?
Meda in the US is headquartered in United States.